Biomarkers of pulmonary hypertension in patients with scleroderma: a case–control study

Author: Zsuzsanna McMahan, Florian Schoenhoff, Jennifer E. Van Eyk, Fredrick M. Wigley and Laura K. Hummers
Date Published: January-2016
Source: Arthritis Research & Therapy

Significant pulmonary vascular disease is a leading cause of death in patients with scleroderma, and early detection and early medical intervention are important, as they may delay disease progression and improve survival and quality of life. Although several biomarkers have been proposed, there remains a need to define a reliable biomarker of early pulmonary vascular disease and subsequent development of pulmonary hypertension (PH). The purpose of this study was to define potential biomarkers for clinically significant pulmonary vascular disease in patients with scleroderma.